Exchange: NASDAQ·Updated 08:43 AM EDT
DWTX logo

DWTX Dogwood Therapeutics Inc.

$1.29
$0.04
(3.20%)
Pre-Market
Prev Close $1.25
Reported EarningsAug 13
Mkt Cap$42.49M
Vol2,273.00

About DWTX

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.
48

Neutral Sentiment

How do you feel about DWTX?

PhishTourFunds
$DWTX Halneuron Phase 2b top line data release next month. There are currently no FDA approved treatments for CINP (chemotherapy-induced neuropathic pain) which makes this tempting. Old school $VIRI crew 👊
1
HeyHoser
$DWTX geez I have not looked at this thing in a while. $1.50 , $50M MC, 10M float... whats the catalyst/play here? Chart looks lovely!
2

Advertisement|Remove ads.